News for Healthier Living

Studies Offer New Insights Into Melanoma Immunotherapy

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators in the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium have identified protein patterns in skin melanoma linked to treatment response after combination immunotherapy. A companion study provides a comprehensive molecular map of melanoma, including protein fragments displayed for immune recognition and chemical modifications of proteins associated with immune suppression and patient survival. Together, the findings could help researchers develop protein-based tests for future melanoma trials and identify proteins to investigate as potential treatment targets. The studies, accepted for coordinated publication in Clinical Cancer Research (DOI: 10.1158/1078-0432.CCR-26-2295-ATR) and Cancer Discovery (DOI: 10.1158/2159-8290.CD-26-0302), both journals of the American Association for Cancer Research, examine melanoma from complementary angles. Their aim was to investigate why some patients wit

November 17, 2026


November 17 2026

November 16 2026

November 15 2026

November 13 2026

November 12 2026

November 11 2026

November 10 2026

November 9 2026

November 8 2026

November 7 2026

November 6 2026

November 5 2026

November 4 2026